| Figure 1‑1: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (1 of 5) |
| Figure 1‑2: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (2 of 5) |
| Figure 1‑3: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (3 of 5) |
| Figure 1‑4: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (4 of 5) |
| Figure 1‑5: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (5 of 5) |
| Figure 1‑6: Companies Researched in This Report |
| Figure 1‑7: Factors Impacting the Cardiac Market by Segment, Europe (1 of 5) |
| Figure 1‑8: Factors Impacting the Cardiac Market by Segment, Europe (2 of 5) |
| Figure 1‑9: Factors Impacting the Cardiac Market by Segment, Europe (3 of 5) |
| Figure 1‑10: Factors Impacting the Cardiac Market by Segment, Europe (4 of 5) |
| Figure 1‑11: Factors Impacting the Cardiac Market by Segment, Europe (5 of 5) |
| Figure 1‑12: Recent Events in the Cardiac Surgery Market, Europe, 2020 – 2023 (1 of 2) |
| Figure 1‑13: Recent Events in the Cardiac Surgery Market, Europe, 2020 – 2023 |
| Figure 1‑14: Cardiac Surgery Procedures Covered, Europe (1 of 3) |
| Figure 1‑15: Cardiac Surgery Procedures Covered, Europe (2 of 3) |
| Figure 1‑16: Cardiac Surgery Procedures Covered, Europe (3 of 3) |
| Figure 1‑17: Cardiac Surgery Markets Covered, Europe (1 of 2) |
| Figure 1‑18: Cardiac Surgery Markets Covered, Europe (2 of 2) |
| Figure 1‑19: Key Report Updates |
| Figure 1‑20: Version History |
| Figure 2‑1: Cardiac Surgery Market by Segment, Worst Case Scenario, Europe, 2020 – 2030 (€M) (1 of 3) |
| Figure 2‑2: Cardiac Surgery Market by Segment, Worst Case Scenario, Europe, 2020 – 2030 (€M) (2 of 3) |
| Figure 2‑3: Cardiac Surgery Market by Segment, Worst Case Scenario, Europe, 2020 – 2030 (€M) (3 of 3) |
| Figure 2‑4: Cardiac Surgery Market by Segment, Base Case Scenario, Europe, 2020 – 2030 (€M) (1 of 3) |
| Figure 2‑5: Cardiac Surgery Market by Segment, Base Case Scenario, Europe, 2020 – 2030 (€M) (2 of 3) |
| Figure 2‑6: Cardiac Surgery Market by Segment, Base Case Scenario, Europe, 2020 – 2030 (€M) (3 of 3) |
| Figure 2‑7: Cardiac Surgery Market by Segment, Best Case Scenario, Europe, 2020 – 2030 (€M) (1 of 3) |
| Figure 2‑8: Cardiac Surgery Market by Segment, Best Case Scenario, Europe, 2020 – 2030 (€M) (2 of 3) |
| Figure 2‑9: Cardiac Surgery Market by Segment, Best Case Scenario, Europe, 2020 – 2030 (€M) (3 of 3) |
| Figure 4‑1: Tissue Heart Valve Devices by Company |
| Figure 4‑2: Mechanical Heart Valve Devices by Company |
| Figure 4‑3: Annuloplasty Repair Devices by Company |
| Figure 4‑4: Transcatheter Mitral Valve Repair Devices by Company |
| Figure 4‑5: Transcatheter Heart Valve Replacement Devices by Company |
| Figure 4‑6: Cerebral Embolic Protection Devices by Company |
| Figure 4‑7: Balloon Valvuloplasty Devices by Company |
| Figure 4‑8: On-Pump Coronary Artery Bypass Devices by Company (1 of 2) |
| Figure 4‑9: On-Pump Coronary Artery Bypass Devices by Company (2 of 2) |
| Figure 4‑10: Off-Pump Coronary Artery Bypass Devices by Company (1 of 2) |
| Figure 4‑11: Off-Pump Coronary Artery Bypass Devices by Company (2 of 2) |
| Figure 4‑12: Autotransfusion Devices by Company |
| Figure 4‑13: Endoscopic Vessel Harvesting Devices by Company |
| Figure 4‑14: Anastomosis Assist Devices by Company |
| Figure 4‑15: Transmyocardial Revascularization Devices by Company |
| Figure 4‑16: Ventricular Assist Devices by Company |
| Figure 4‑17: Intra-Aortic Balloon Pump Devices by Company |
| Figure 4‑18: Artificial Heart Replacement Devices by Company |
| Figure 4‑19: Patent Foramen Ovale Devices by Company |
| Figure 4‑20: Patent Ductus Arteriosus Closure Devices by Company |
| Figure 4‑21: Atrial & Ventricular Septal Defect Devices by Company |
| Figure 4‑22: Left Atrial Appendage Closure Devices by Company |
| Figure 4‑23: Preshaped Guidewires by Company |
| Figure 4‑24: Extracorporeal Membrane Oxygenation by Company (1 of 2) |
| Figure 4‑25: ECMO by Company (2 of 2) |
| Figure 4‑26: Class 2 Device Recall CryoValve SG Pulmonary Human Heart Valve |
| Figure 4‑27: Class 2 Device Recall PERCEVAL SUTURELESS HEART VALVE |
| Figure 4‑28: Class 2 Device Recall Hancock II T510 Bioprosthesis |
| Figure 4‑29: Class 2 Device Recall Mosaic 310 Bioprosthesis |
| Figure 4‑30: Class 2 Device Recall Cryovalve(R) SG Pulmonary Human Heart Valve |
| Figure 4‑31: Class 2 Device Recall, CryoLife |
| Figure 4‑32: Class 2 Device Recall Medtronic Open Pivot Aortic Valve Graft |
| Figure 4‑33: Class 2 Device Recall OnX Aortic Heart Valve |
| Figure 4‑34: Class 1 Device Recall, CryoLife |
| Figure 4‑35: Class 2 Device Recall Medtronic Simulus 850 Semi Rigid Ring/Band Accessory Kit |
| Figure 4‑36: Class 2 Device Recall Medtronic Simulus 750 Flexible Ring/Band Accessory Kit |
| Figure 4‑37: Class 2 Device Recall MitraClip" and TriClip" Delivery System(s) |
| Figure 4‑38: Class 2 Device Recall Abbott MitraClip XTR Clip Delivery System |
| Figure 4‑39: Class 2 Device Recall, Abbott |
| Figure 4‑40: Class 1 Device Recall Harmony Delivery Catheter System |
| Figure 4‑41: Class 1 Device Recall Lotus Edge Valve System |
| Figure 4‑42: Class 1 Device Recall Edwards Sapien 3 Ultra Delivery System |
| Figure 4‑43: Class 2 Device Recall Edwards SAPIEN 3 Transcatheter Heart Valve (THV) |
| Figure 4‑44: Class 2 Device Recall Quadroxi Pediatric |
| Figure 4‑45: Class 2 Device Recall QUADROXi Small Adult |
| Figure 4‑46: Class 2 Device Recall QUADROX i Neonatal |
| Figure 4‑47: Class 2 Device Recall QUADROXi Small Adult, BIOLINE Coated |
| Figure 4‑48: Class 2 Device Recall QUADROX iR |
| Figure 4‑49: Class 2 Device Recall Quadroxi Adult |
| Figure 4‑50: Class 2 Device Recall QUADROXi Small |
| Figure 4‑51: Class 2 Device Recall CAPIOX NX19 |
| Figure 4‑52: Class 2 Device Recall CAPIOX RX15 |
| Figure 4‑53: Class 2 Device Recall CAPIOX FX25 |
| Figure 4‑54: Class 2 Device Recall Affinity Fusion Oxygenator |
| Figure 4‑55: Class 1 Device Recall LifeSPARC Controller |
| Figure 4‑56: Class 1 Device Recall Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface |
| Figure 4‑57: Class 2 Device Recall Capiox FX25 Advance Oxygenator |
| Figure 4‑58: Class 3 Device Recall ROTAFLOW Centrifugal Pump System |
| Figure 4‑59: Class 2 Device Recall ROTAFLOW Centrifugal Pump System |
| Figure 4‑60: Class 2 Device Recall Maquet/Getinge |
| Figure 4‑61: Class 3 Device Recall Smart Perfusion Pack |
| Figure 4‑62: Class 2 Device Recall Terumo Capiox NX19 Oxygenator |
| Figure 4‑63: Class 2 Device Recall |
| Figure 4‑64: Class 2 Device Recall ACROBAT V |
| Figure 4‑65: Class 2 Device Recall ACROBAT SUV |
| Figure 4‑66: Class 2 Device Recall ACROBATi |
| Figure 4‑67: Class 2 Device Recall CS Elite Fastpack |
| Figure 4‑68: Class 2 Device Recall CS Elite |
| Figure 4‑69: Class 2 Device Recall CS5/5 Fastpacks |
| Figure 4‑70: Class 2 Device Recall Cell Saver |
| Figure 4‑71: Class 2 Device Recall High Speed Cell Saver |
| Figure 4‑72: Class 2 Device Recall CSE Set |
| Figure 4‑73: Class 2 Device Recall CATSmart Autotransfusion |
| Figure 4‑74: Class 2 Device Recall CATSmart Vacuum Pump |
| Figure 4‑75: Class 2 Device Recall VASOVIEW HEMOPRO |
| Figure 4‑76: Class 2 Device Recall VASOVIEW HEMOPRO 2 |
| Figure 4‑77: Class 2 Device Recall Cardica CPort xA PLUS Anastomosis System |
| Figure 4‑78: Class 2 Device Recall HeartWare" Ventricular Assist Device (HVAD") System |
| Figure 4‑79: Class 1 Device Recall Impella RP Flex with SmartAssist |
| Figure 4‑80: Class 1 Device Recall Impella LD |
| Figure 4‑81: Class 1 Device Recall Impella CP with SmartAssist |
| Figure 4‑82: Class 1 Device Recall Impella 5.0 |
| Figure 4‑83: Class 1 Device Recall Impella 2.5 |
| Figure 4‑84: Class 1 Device Recall Impella CP |
| Figure 4‑85: Class 2 Device Recall HeartWare |
| Figure 4‑86: Class 1 Device Recall Heartware HVAD |
| Figure 4‑87: Class 1 Device Recall HeartWare HVAD Pump Implant Kit |
| Figure 4‑88: Class 2 Device Recall HeartWare Ventricular Assist Device (HVAD) System |
| Figure 4‑89: Class 2 Device Recall HeartWare HVAD System |
| Figure 4‑90: Class 2 Device Recall HeartMate Touch Communication System |
| Figure 4‑91: Class 2 Device Recall TandemHeart Pump |
| Figure 4‑92: Class 1 Device Recall HVAD Pump Implant Kit |
| Figure 4‑93: Class 1 Device Recall HVAD Pump Outflow Graft |
| Figure 4‑94: Class 2 Device Recall HeartMate 3 Left Ventricular Assist System |
| Figure 4‑95: Class 2 Device Recall HeartMate Left Ventricular Assist System |
| Figure 4‑96: Class 2 Device Recall HeartMate Outflow Graft |
| Figure 4‑97: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP) |
| Figure 4‑98: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP) |
| Figure 4‑99: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP) |
| Figure 4‑100: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP) |
| Figure 4‑101: Class 2 Device Recall Cardiosave Rescue |
| Figure 4‑102: Class 2 Device Recall Safety Disk |
| Figure 4‑103: Class 2 Device Recall Cardiosave Rescue |
| Figure 4‑104: Class 2 Device Recall Cardiosave Hybrid |
| Figure 4‑105: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP) |
| Figure 4‑106: Class 1 Device Recall Arrow AutoCAT2 |
| Figure 4‑107: Class 1 Device Recall Arrow AC3 Optimus |
| Figure 4‑108: Class 1 Device Recall AutoCAT IABP Series |
| Figure 4‑109: Class 1 Device Recall Arrow AutoCAT2 |
| Figure 4‑110: Class 1 Device Recall AC3 Series IABP System |
| Figure 4‑111: Class 2 Device Recall SynCardia temporary Total Artificial Heart System |
| Figure 4‑112: Class 2 Device Recall Gore Cardioform Septal Occluder |
| Figure 4‑113: Class 2 Device Recall GORE CARDIOFORM SEPTAL OCCLUDER |
| Figure 4‑114: Class 2 Device Recall GORE CARDIOFORM ASD Occluder |
| Figure 4‑115: Class 2 Device Recall Lunderquist Ring Torque Wire Guide |
| Figure 4‑116: Class 1 Device Recall Medtronic Confida Expandable Sheath |
| Figure 4‑117: Class 2 Device Recall HLS Set Advanced |
| Figure 4‑118: Class 2 Device Recall HLS Set Advanced |
| Figure 4‑119: Class 3 Device Recall Cardiac Assist |
| Figure 4‑120: Class 2 Device Recall TandemHeart Pump |
| Figure 4‑121: Class 1 Device Recall CentriMag Acute Circulatory Support System Motor |
| Figure 4‑122: INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study (INVIVITY) |
| Figure 4‑123: Avalus European Registry - an Observational Study to Evaluate Safety and Efficacy in a Real World Population |
| Figure 4‑124: PERCEVAL S Valve Clinical Study for Chinese Registration (PERFECT) |
| Figure 4‑125: INSPIRIS RESILIA Valve in Pulmonary Position |
| Figure 4‑126: Trifecta and Epic ViV Detailed Insights into Management Strategies and Outcomes |
| Figure 4‑127: Trifecta™ Long Term Follow-Up (LTFU) Study |
| Figure 4‑128: Post Market Clinical Follow-Up Study in Patients Treated with the On-X Ascending Aortic Prosthesis (AAP) (ASCEND) |
| Figure 4‑129: Regent China Post-Market Clinical Follow-up Study |
| Figure 4‑130: SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy |
| Figure 4‑131: Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve |
| Figure 4‑132: HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve |
| Figure 4‑133: On-X Heart Valve - 17mm Aortic and 23mm Mitral |
| Figure 4‑134: HAART Annuloplasty Device Valve Repair Registry |
| Figure 4‑135: Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study (ARB-PMCF) |
| Figure 4‑136: A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation |
| Figure 4‑137: Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty with 3D Shaped Rings |
| Figure 4‑138: PRESERVE-MITRAL Post-Market Registry |
| Figure 4‑139: Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients with Mitral Valve Disease |
| Figure 4‑140: Valveclip® Transcatheter Mitral Valve Repair Study |
| Figure 4‑141: Caisson Transcatheter Mitral Valve Replacement (TMVR) (INTERLUDE) |
| Figure 4‑142: Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients with Severe Primary Mitral Regurgitation Eligible for High-risk Surgery (MITRA-HR) |
| Figure 4‑143: Mi-thos® Transcatheter Mitral Valve Replacement (First-in-Man Study) |
| Figure 4‑144: MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR (EVOLVE-MR) |
| Figure 4‑145: The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices |
| Figure 4‑146: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population (China XT) |
| Figure 4‑147: The PROTEMBO Trial |
| Figure 4‑148: PROTECT TAVI – Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection with the Sentinel™ Device |
| Figure 4‑149: Transcatheter Aortic Valve Replacement (TAVR) Double Balloon Valvuloplasty |
| Figure 4‑150: Mini-invasive Balloon Aortic Valvuloplasty |
| Figure 4‑151: Comparison of Saphenous Vein Harvesting by Endoscopic Versus Open Conventional Methods |
| Figure 4‑152: CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study |
| Figure 4‑153: LVAD Conditioning for Cardiac Recovery |
| Figure 4‑154: EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study |
| Figure 4‑155: Effect of Cardiac Resynchronization Therapy (CRT) on Left Ventricular Assist Device (LVAD) Function |
| Figure 4‑156: The Left Ventricular Assist Device (LVAD) Off or On Pump Implantation Study |
| Figure 4‑157: A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System |
| Figure 4‑158: Outcome of Patients Treated with IABP |
| Figure 4‑159: Intra-Aortic Balloon Pump in Extensive Myocardial Infarction with Persistent Ischemia |
| Figure 4‑160: Carmat Total Artificial Heart as a Bridge to Transplant in Patients with Advanced Heart Failure |
| Figure 4‑161: SynCardia 70cc TAH-t for Destination Therapy |
| Figure 4‑162: Syncardia 50cc TAH-t as a Bridge to Transplant |
| Figure 4‑163: AMPLATZER PFO Occluder Post Approval Study |
| Figure 4‑164: GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study |
| Figure 4‑165: GORE® CARDIOFORM Septal Occluder Migraine Clinical Study |
| Figure 4‑166: Evaluation of the Efficacy and Safety of a Simplified Procedure for the Percutaneous Closure of the Patent Foramen Ovale |
| Figure 4‑167: Amplatzer PFO Occluder Post-marketing Surveillance Study |
| Figure 4‑168: Internal Microstructure of Patent Foramen Ovale Related to Stroke |
| Figure 4‑169: Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes |
| Figure 4‑170: Amplatzer Piccolo Occluder Japan Post-Marketing Database Surveillance |
| Figure 4‑171: Nit-Occlud PDA Post-Approval Study |
| Figure 4‑172: Procedural Outcomes of Percutaneous PDA Closure: Comparative Study between Different Devices |
| Figure 4‑173: A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography |
| Figure 4‑174: The ICE WATCHMAN Trial |
| Figure 4‑175: VClip Post-Market Study |
| Figure 4‑176: Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong |
| Figure 4‑177: AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures |
| Figure 4‑178: CentriMag Failure-to-Wean Post Approval Study |
| Figure 4‑179: Quality of Life 1y and 2 y After VV-ECMO for COVID-19 |
| Figure 4‑180: ECMO Treatment of Children in China in the Past 10 Years |
| Figure 4‑181: TandemHeart Experiences and MEthods |
| Figure 5‑1: Currency Exchange Rate, 2023 |
| Figure 5‑2: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (€M) (1 of 3) |
| Figure 5‑3: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (€M) (2 of 3) |
| Figure 5‑4: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (€M) (3 of 3) |
| Figure 5‑5: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (US$M) (1 of 3) |
| Figure 5‑6: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (US$M) (2 of 3) |
| Figure 5‑7: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (US$M) (3 of 3) |
| Figure 5‑8: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (1 of 4) |
| Figure 5‑9: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (2 of 4) |
| Figure 5‑10: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (3 of 4) |
| Figure 5‑11: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (4 of 4) |
| Figure 5‑12: Other Notable Competitors, Cardiac Surgery Market, Europe, 2023 |
| Figure 5‑13: SWOT Analysis, Abbott (1 of 2) |
| Figure 5‑14: SWOT Analysis, Abbott (2 of 2) |
| Figure 5‑15: SWOT Analysis, Abiomed |
| Figure 5‑16: SWOT Analysis, Artivion |
| Figure 5‑17: SWOT Analysis, AtriCure |
| Figure 5‑18: SWOT Analysis, B. Braun |
| Figure 5‑19: SWOT Analysis, Boston Scientific |
| Figure 5‑20: SWOT Analysis, Edwards Lifesciences |
| Figure 5‑21: SWOT Analysis, Getinge |
| Figure 5‑22: SWOT Analysis, LivaNova |
| Figure 5‑23: SWOT Analysis, Medtronic |
| Figure 5‑24: SWOT Analysis, Terumo |
| Figure 7‑1: Total Cardiac Surgery Procedures by Segment, Europe, 2020 – 2030 (1 of 3) |
| Figure 7‑2: Total Cardiac Surgery Procedures by Segment, Europe, 2020 – 2030 (2 of 3) |
| Figure 7‑3: Total Cardiac Surgery Procedures by Segment, Europe, 2020 – 2030 (3 of 3) |
| Figure 7‑4: Total Cardiac Surgery Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑5: Surgical Heart Valve Replacement Procedures by Type, Europe, 2020 – 2030 |
| Figure 7‑6: Surgical Heart Valve Replacement Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑7: Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑8: Tissue Heart Valve Procedures by Valve Type, Europe, 2020 – 2030 |
| Figure 7‑9: Aortic Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑10: Mitral Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑11: Tricuspid Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑12: Pulmonary Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑13: Tissue Heart Valve Procedures by Material Type, Europe, 2020 – 2030 |
| Figure 7‑14: Xenograft Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑15: Allograft Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑16: Tissue Heart Valve Procedures by Device Type, Europe, 2020 – 2030 |
| Figure 7‑17: Stented Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑18: Stentless Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑19: Sutureless/Rapid Deployment Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑20: Mechanical Heart Valve Procedures by Valve Type, Europe, 2020 – 2030 |
| Figure 7‑21: Total Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑22: Aortic Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑23: Mitral Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑24: Tricuspid Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑25: Pulmonary Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑26: Annuloplasty Repair Procedures by Valve Type, Europe, 2020 – 2030 |
| Figure 7‑27: Annuloplasty Repair Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑28: Mitral Annuloplasty Repair Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑29: Tricuspid Annuloplasty Repair Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑30: TMVr Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑31: TAVR Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑32: TAVR Procedures by Approach, Europe, 2020 – 2030 |
| Figure 7‑33: Transfemoral TAVR Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑34: Transapical TAVR Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑35: Other TAVR Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑36: TAVR Procedures by Patient Risk Class, Europe, 2023 |
| Figure 7‑37: TAVR Procedures by Embolic Protection, Europe, 2020 – 2030 |
| Figure 7‑38: TAVR Procedures with Cerebral Embolic Protection by Country, Europe, 2020 – 2030 |
| Figure 7‑39: TAVR Procedures without Cerebral Embolic Protection by Country, Europe, 2020 – 2030 |
| Figure 7‑40: TPVR Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑41: TMV Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑42: Balloon Valvuloplasty Procedures by Device Type, Europe, 2020 – 2030 |
| Figure 7‑43: Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑44: Aortic Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑45: Mitral Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑46: Pulmonary Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑47: CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑48: CABG Procedures by Support, Europe, 2020 – 2030 |
| Figure 7‑49: OPCAB CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑50: ONCAB CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑51: MISC/MIDCAB CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑52: CABG Procedures by Support, Europe, 2020 – 2030 |
| Figure 7‑53: Open Vessel Harvesting CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑54: Endoscopic Vessel Harvesting CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑55: CABG Procedures by Support, Europe, 2020 – 2030 |
| Figure 7‑56: Traditional Suture CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑57: Anastomosis Assist Device CABG Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑58: Autotransfusion Procedures by Type, Europe, 2020 – 2030 |
| Figure 7‑59: Autotransfusion Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑60: Cardiovascular and Other Autotransfusion Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑61: Orthopedic Autotransfusion Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑62: Ventricular Assist Device Procedures by Type, Europe, 2020 – 2030 |
| Figure 7‑63: pVAD Procedures by Heart Side, Europe, 2020 – 2030 |
| Figure 7‑64: Left Heart pVAD Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑65: Right Heart pVAD Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑66: Destination Therapy Implantable VAD Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑67: Bridge-to-Transplant Implantable VAD Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑68: Bridge-to-Recovery Implantable VAD Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑69: IABP Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑70: Artificial Heart Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑71: PFO Closure Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑72: PDA Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑73: Total Septal Defect Procedures by Type, Europe, 2020 – 2030 |
| Figure 7‑74: Septal Defect Closure Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑75: Atrial Septal Defect Closure Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑76: Ventricular Septal Defect Closure Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑77: Left Atrial Appendage Closure Device Procedures by Type, Europe, 2020 – 2030 |
| Figure 7‑78: LAA Closure Device Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑79: Endocardial Closure Device Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑80: Epicardial Clip Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑81: Epicardial Suture Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑82: TMR Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑83: ECMO Procedures by Modality, Europe, 2020 – 2030 |
| Figure 7‑84: ECMO Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑85: VA ECMO Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑86: VV ECMO Procedures by Country, Europe, 2020 – 2030 |
| Figure 7‑87: AV ECMO Procedures by Country, Europe, 2020 – 2030 |
| Figure 8‑1: Tissue Heart Valve Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 8‑2: Tissue Heart Valve Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 8‑3: Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑4: Units Sold by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑5: Average Selling Price by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (€) |
| Figure 8‑6: Average Selling Price by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (US$) |
| Figure 8‑7: Market Value by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (€M) |
| Figure 8‑8: Market Value by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M) |
| Figure 8‑9: Stented Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑10: Units Sold by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑11: Average Selling Price by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (€) |
| Figure 8‑12: Average Selling Price by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (US$) |
| Figure 8‑13: Market Value by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (€M) |
| Figure 8‑14: Market Value by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M) |
| Figure 8‑15: Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑16: Units Sold by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑17: Average Selling Price by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (€) |
| Figure 8‑18: Average Selling Price by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (US$) |
| Figure 8‑19: Market Value by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (€M) |
| Figure 8‑20: Market Value by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M) |
| Figure 8‑21: Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑22: Units Sold by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 |
| Figure 8‑23: Average Selling Price by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (€) |
| Figure 8‑24: Average Selling Price by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (US$) |
| Figure 8‑25: Market Value by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (€M) |
| Figure 8‑26: Market Value by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M) |
| Figure 8‑27: Leading Competitors, Tissue Heart Valve Market, Europe, 2023 |
| Figure 9‑1: Mechanical Heart Valve Market, Europe, 2020 – 2030 |
| Figure 9‑2: Units Sold by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 |
| Figure 9‑3: Average Selling Price by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (€) |
| Figure 9‑4: Average Selling Price by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (US$) |
| Figure 9‑5: Market Value by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (€M) |
| Figure 9‑6: Market Value by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (US$M) |
| Figure 9‑7: Leading Competitors, Mechanical Heart Valve Market, Europe, 2023 |
| Figure 10‑1: Annuloplasty Repair Device Market, Europe, 2020 – 2030 |
| Figure 10‑2: Units Sold by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 |
| Figure 10‑3: Average Selling Price by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (€) |
| Figure 10‑4: Average Selling Price by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (US$) |
| Figure 10‑5: Market Value by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (€M) |
| Figure 10‑6: Market Value by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 10‑7: Leading Competitors, Annuloplasty Repair Device Market, Europe, 2023 |
| Figure 11‑1: Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 |
| Figure 11‑2: Units Sold by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 |
| Figure 11‑3: Average Selling Price by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (€) |
| Figure 11‑4: Average Selling Price by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (US$) |
| Figure 11‑5: Market Value by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (€M) |
| Figure 11‑6: Market Value by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (US$M) |
| Figure 11‑7: Leading Competitors, Transcatheter Mitral Valve Repair Market, Europe, 2023 |
| Figure 12‑1: Transcatheter Heart Valve Replacement Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 12‑2: Transcatheter Heart Valve Replacement Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 12‑3: Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 |
| Figure 12‑4: Units Sold by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 |
| Figure 12‑5: Average Selling Price by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (€) |
| Figure 12‑6: Average Selling Price by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (US$) |
| Figure 12‑7: Market Value by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (€M) |
| Figure 12‑8: Market Value by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (US$M) |
| Figure 12‑9: TAVR Market, Europe, 2020 – 2030 |
| Figure 12‑10: Units Sold by Country, TAVR Market, Europe, 2020 – 2030 |
| Figure 12‑11: Average Selling Price by Country, TAVR Market, Europe, 2020 – 2030 (€) |
| Figure 12‑12: Average Selling Price by Country, TAVR Market, Europe, 2020 – 2030 (US$) |
| Figure 12‑13: Market Value by Country, TAVR Market, Europe, 2020 – 2030 (€M) |
| Figure 12‑14: Market Value by Country, TAVR Market, Europe, 2020 – 2030 (US$M) |
| Figure 12‑15: TPVR Market, Europe, 2020 – 2030 |
| Figure 12‑16: Units Sold by Country, TPVR Market, Europe, 2020 – 2030 |
| Figure 12‑17: Average Selling Price by Country, TPVR Market, Europe, 2020 – 2030 (€) |
| Figure 12‑18: Average Selling Price by Country, TPVR Market, Europe, 2020 – 2030 (US$) |
| Figure 12‑19: Market Value by Country, TPVR Market, Europe, 2020 – 2030 (€M) |
| Figure 12‑20: Market Value by Country, TPVR Market, Europe, 2020 – 2030 (US$M) |
| Figure 12‑21: TMVR Market, Europe, 2020 – 2030 |
| Figure 12‑22: Units Sold by Country, TMVR Market, Europe, 2020 – 2030 |
| Figure 12‑23: Average Selling Price by Country, TMVR Market, Europe, 2020 – 2030 (€) |
| Figure 12‑24: Average Selling Price by Country, TMVR Market, Europe, 2020 – 2030 (US$) |
| Figure 12‑25: Market Value by Country, TMVR Market, Europe, 2020 – 2030 (€M) |
| Figure 12‑26: Market Value by Country, TMVR Market, Europe, 2020 – 2030 (US$M) |
| Figure 12‑27: Leading Competitors, Transcatheter Heart Valve Replacement Market, Europe, 2023 |
| Figure 12‑28: Leading Competitors by Country, Transcatheter Aortic Valve Replacement Market, Europe, 2023 |
| Figure 13‑1: Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 |
| Figure 13‑2: Units Sold by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 |
| Figure 13‑3: Average Selling Price by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (€) |
| Figure 13‑4: Average Selling Price by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (US$) |
| Figure 13‑5: Market Value by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (€M) |
| Figure 13‑6: Market Value by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 13‑7: Leading Competitors by Country, Cerebral Embolic Protection Device Market, Europe, 2023 |
| Figure 14‑1: Balloon Valvuloplasty Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 14‑2: Balloon Valvuloplasty Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 14‑3: Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑4: Units Sold by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑5: Average Selling Price by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€) |
| Figure 14‑6: Average Selling Price by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$) |
| Figure 14‑7: Market Value by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M) |
| Figure 14‑8: Market Value by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M) |
| Figure 14‑9: Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑10: Units Sold by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑11: Average Selling Price by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€) |
| Figure 14‑12: Average Selling Price by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$) |
| Figure 14‑13: Market Value by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M) |
| Figure 14‑14: Market Value by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M) |
| Figure 14‑15: Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑16: Units Sold by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑17: Average Selling Price by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€) |
| Figure 14‑18: Average Selling Price by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$) |
| Figure 14‑19: Market Value by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M) |
| Figure 14‑20: Market Value by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M) |
| Figure 14‑21: Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑22: Units Sold by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 |
| Figure 14‑23: Average Selling Price by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€) |
| Figure 14‑24: Average Selling Price by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$) |
| Figure 14‑25: Market Value by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M) |
| Figure 14‑26: Market Value by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M) |
| Figure 14‑27: Leading Competitors, Balloon Valvuloplasty Market, Europe, 2023 |
| Figure 15‑1: ONCAB Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 15‑2: ONCAB Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 15‑3: ONCAB Disposables Market, Europe, 2020 – 2030 |
| Figure 15‑4: Units Sold by Country, ONCAB Disposables Market, Europe, 2020 – 2030 |
| Figure 15‑5: Average Selling Price by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (€) |
| Figure 15‑6: Average Selling Price by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (US$) |
| Figure 15‑7: Market Value by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (€M) |
| Figure 15‑8: Market Value by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (US$M) |
| Figure 15‑9: Perfusion System Market, Europe, 2020 – 2030 |
| Figure 15‑10: Units Sold by Country, Perfusion System Market, Europe, 2020 – 2030 |
| Figure 15‑11: Average Selling Price by Country, Perfusion System Market, Europe, 2020 – 2030 (€) |
| Figure 15‑12: Average Selling Price by Country, Perfusion System Market, Europe, 2020 – 2030 (US$) |
| Figure 15‑13: Market Value by Country, Perfusion System Market, Europe, 2020 – 2030 (€M) |
| Figure 15‑14: Market Value by Country, Perfusion System Market, Europe, 2020 – 2030 (US$M) |
| Figure 15‑15: Leading Competitors, ONCAB Market, Europe, 2023 |
| Figure 16‑1: OPCAB Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 16‑2: OPCAB Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 16‑3: OPCAB Market, Europe, 2020 – 2030 |
| Figure 16‑4: Units Sold by Country, OPCAB Market, Europe, 2020 – 2030 |
| Figure 16‑5: Average Selling Price by Country, OPCAB Market, Europe, 2020 – 2030 (€) |
| Figure 16‑6: Average Selling Price by Country, OPCAB Market, Europe, 2020 – 2030 (US$) |
| Figure 16‑7: Market Value by Country, OPCAB Market, Europe, 2020 – 2030 (€M) |
| Figure 16‑8: Market Value by Country, OPCAB Market, Europe, 2020 – 2030 (US$M) |
| Figure 16‑9: Stabilizer Device Market, Europe, 2020 – 2030 |
| Figure 16‑10: Units Sold by Country, Stabilizer Device Market, Europe, 2020 – 2030 |
| Figure 16‑11: Average Selling Price by Country, Stabilizer Device Market, Europe, 2020 – 2030 (€) |
| Figure 16‑12: Average Selling Price by Country, Stabilizer Device Market, Europe, 2020 – 2030 (US$) |
| Figure 16‑13: Market Value by Country, Stabilizer Device Market, Europe, 2020 – 2030 (€M) |
| Figure 16‑14: Market Value by Country, Stabilizer Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 16‑15: Positioner Market, Europe, 2020 – 2030 |
| Figure 16‑16: Units Sold by Country, Positioner Market, Europe, 2020 – 2030 |
| Figure 16‑17: Average Selling Price by Country, Positioner Market, Europe, 2020 – 2030 (€) |
| Figure 16‑18: Average Selling Price by Country, Positioner Market, Europe, 2020 – 2030 (US$) |
| Figure 16‑19: Market Value by Country, Positioner Market, Europe, 2020 – 2030 (€M) |
| Figure 16‑20: Market Value by Country, Positioner Market, Europe, 2020 – 2030 (US$M) |
| Figure 16‑21: Leading Competitors, OPCAB Market, Europe, 2023 |
| Figure 17‑1: Autotransfusion Device Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 17‑2: Autotransfusion Device Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 17‑3: Autotransfusion Machine Market, Europe, 2020 – 2030 |
| Figure 17‑4: Units Sold by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 |
| Figure 17‑5: Average Selling Price by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (€) |
| Figure 17‑6: Average Selling Price by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (US$) |
| Figure 17‑7: Market Value by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (€M) |
| Figure 17‑8: Market Value by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (US$M) |
| Figure 17‑9: Autotransfusion Disposables Market, Europe, 2020 – 2030 |
| Figure 17‑10: Units Sold by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 |
| Figure 17‑11: Average Selling Price by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (€) |
| Figure 17‑12: Average Selling Price by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (US$) |
| Figure 17‑13: Market Value by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (€M) |
| Figure 17‑14: Market Value by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (US$M) |
| Figure 17‑15: Leading Competitors, Autotransfusion Device Market, Europe, 2023 |
| Figure 18‑1: Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 |
| Figure 18‑2: Units Sold by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 |
| Figure 18‑3: Average Selling Price by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (€) |
| Figure 18‑4: Average Selling Price by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (US$) |
| Figure 18‑5: Market Value by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (€M) |
| Figure 18‑6: Market Value by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 18‑7: Leading Competitors, Endoscopic Vessel Harvesting Device Market, Europe, 2023 |
| Figure 19‑1: Anastomosis Assist Device Market, Europe, 2020 – 2030 |
| Figure 19‑2: Units Sold by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 |
| Figure 19‑3: Average Selling Price by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (€) |
| Figure 19‑4: Average Selling Price by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (US$) |
| Figure 19‑5: Market Value by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (€M) |
| Figure 19‑6: Market Value by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 19‑7: Leading Competitors, Anastomosis Assist Device Market, Europe, 2023 |
| Figure 20‑1: Transmyocardial Revascularization Device Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 20‑2: Transmyocardial Revascularization Device Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 20‑3: Single-Use Fiber-Optic Handpiece Market, Europe, 2020 – 2030 |
| Figure 20‑4: Transmyocardial Revascularization Laser Console Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 20‑5: Transmyocardial Revascularization Laser Console Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 20‑6: Leading Competitors, TMR Device Market, Europe, 2023 |
| Figure 21‑1: Ventricular Assist Device Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 21‑2: Ventricular Assist Device Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 21‑3: Ventricular Assist Device Market, Europe, 2020 – 2030 |
| Figure 21‑4: Units Sold by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 |
| Figure 21‑5: Average Selling Price by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (€) |
| Figure 21‑6: Average Selling Price by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (US$) |
| Figure 21‑7: Market Value by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (€M) |
| Figure 21‑8: Market Value by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 21‑9: pVAD Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 21‑10: pVAD Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 21‑11: Total pVAD Market, Europe, 2020 – 2030 |
| Figure 21‑12: Units Sold by Country, Total pVAD Market, Europe, 2020 – 2030 |
| Figure 21‑13: Average Selling Price by Country, Total pVAD Market, Europe, 2020 – 2030 (€) |
| Figure 21‑14: Average Selling Price by Country, Total pVAD Market, Europe, 2020 – 2030 (US$) |
| Figure 21‑15: Market Value by Country, Total pVAD Market, Europe, 2020 – 2030 (€M) |
| Figure 21‑16: Market Value by Country, Total pVAD Market, Europe, 2020 – 2030 (US$M) |
| Figure 21‑17: Left Heart pVAD Market, Europe, 2020 – 2030 |
| Figure 21‑18: Units Sold by Country, Left Heart pVAD Market, Europe, 2020 – 2030 |
| Figure 21‑19: Average Selling Price by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (€) |
| Figure 21‑20: Average Selling Price by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (US$) |
| Figure 21‑21: Market Value by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (€M) |
| Figure 21‑22: Market Value by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (US$M) |
| Figure 21‑23: Right Heart pVAD Market, Europe, 2020 – 2030 |
| Figure 21‑24: Units Sold by Country, Right Heart pVAD Market, Europe, 2020 – 2030 |
| Figure 21‑25: Average Selling Price by Country, Right Heart pVAD Market, Europe, 2020 – 2030 (€) |
| Figure 21‑26: Average Selling Price by Country, Right Heart pVAD Market, Europe, 2020 – 2030 (US$) |
| Figure 21‑27: Market Value by Country, Right Heart pVAD Market, Europe, 2020 – 2030 (€M) |
| Figure 21‑28: Market Value by Country, Right Heart pVAD Market, Europe, 2020– 2030 (US$M) |
| Figure 21‑29: Implantable VAD Market, Europe, 2020 – 2030 |
| Figure 21‑30: Units Sold by Country, Implantable VAD Market, Europe, 2020 – 2030 |
| Figure 21‑31: Average Selling Price by Country, Implantable VAD Market, Europe, 2020 – 2030 (€) |
| Figure 21‑32: Average Selling Price by Country, Implantable VAD Market, Europe, 2020 – 2030 (US$) |
| Figure 21‑33: Market Value by Country, Implantable VAD Market, Europe, 2020 – 2030 (€M) |
| Figure 21‑34: Market Value by Country, Implantable VAD Market, Europe, 2020 – 2030 (US$M) |
| Figure 21‑35: Leading Competitors, Ventricular Assist Device Market, Europe, 2023 |
| Figure 22‑1: Intra-Aortic Balloon Device Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 22‑2: Intra-Aortic Balloon Device Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 22‑3: IAB Catheter Market, Europe, 2020 – 2030 |
| Figure 22‑4: Units Sold by Country, IAB Catheter Market, Europe, 2020 – 2030 |
| Figure 22‑5: Average Selling Price by Country, IAB Catheter Market, Europe, 2020 – 2030 (€) |
| Figure 22‑6: Average Selling Price by Country, IAB Catheter Market, Europe, 2020 – 2030 (US$) |
| Figure 22‑7: Market Value by Country, IAB Catheter Market, Europe, 2020 – 2030 (€M) |
| Figure 22‑8: Market Value by Country, IAB Catheter Market, Europe, 2020 – 2030 (US$M) |
| Figure 22‑9: IABP Console Market, Europe, 2020 – 2030 |
| Figure 22‑10: Units Sold by Country, IABP Console Market, Europe, 2020 – 2030 |
| Figure 22‑11: Installed Base by Country, IABP Console Market, Europe, 2020 – 2030 |
| Figure 22‑12: Average Selling Price by Country, IABP Console Market, Europe, 2020 – 2030 (€) |
| Figure 22‑13: Average Selling Price by Country, IABP Console Market, Europe, 2020 – 2030 (US$) |
| Figure 22‑14: Market Value by Country, IABP Console Market, Europe, 2020 – 2030 (€M) |
| Figure 22‑15: Market Value by Country, IABP Console Market, Europe, 2020 – 2030 (US$M) |
| Figure 22‑16: Leading Competitors, Intra-Aortic Balloon Device Market, Europe, 2023 |
| Figure 23‑1: Artificial Heart Device Market, Europe, 2020 – 2030 |
| Figure 23‑2: Units Sold by Country, Artificial Heart Device Market, Europe, 2020 – 2030 |
| Figure 23‑3: Average Selling Price by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (€) |
| Figure 23‑4: Average Selling Price by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (US$) |
| Figure 23‑5: Market Value by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (€M) |
| Figure 23‑6: Market Value by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 23‑7: Leading Competitors, Artificial Heart Device Market, Europe, 2023 |
| Figure 24‑1: Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 |
| Figure 24‑2: Units Sold by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 |
| Figure 24‑3: Average Selling Price by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (€) |
| Figure 24‑4: Average Selling Price by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (US$) |
| Figure 24‑5: Market Value by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (€M) |
| Figure 24‑6: Market Value by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 24‑7: Leading Competitors, Patent Foramen Ovale Closure Device Market, Europe, 2023 |
| Figure 25‑1: Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 |
| Figure 25‑2: Units Sold by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 |
| Figure 25‑3: Average Selling Price by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (€) |
| Figure 25‑4: Average Selling Price by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (US$) |
| Figure 25‑5: Market Value by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (€M) |
| Figure 25‑6: Market Value by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 25‑7: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, Europe, 2023 |
| Figure 26‑1: Atrial & Ventricular Septal Defect Closure Device Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 26‑2: Atrial & Ventricular Septal Defect Closure Device Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 26‑3: Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 |
| Figure 26‑4: Units Sold by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 |
| Figure 26‑5: Average Selling Price by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€) |
| Figure 26‑6: Average Selling Price by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$) |
| Figure 26‑7: Market Value by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€M) |
| Figure 26‑8: Market Value by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 26‑9: Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 |
| Figure 26‑10: Units Sold by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 |
| Figure 26‑11: Average Selling Price by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (€) |
| Figure 26‑12: Average Selling Price by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$) |
| Figure 26‑13: Market Value by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (€M) |
| Figure 26‑14: Market Value by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 26‑15: Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 |
| Figure 26‑16: Units Sold by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 |
| Figure 26‑17: Average Selling Price by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€) |
| Figure 26‑18: Average Selling Price by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$) |
| Figure 26‑19: Market Value by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€M) |
| Figure 26‑20: Market Value by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 26‑21: Leading Competitors, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2023 |
| Figure 27‑1: Left Atrial Appendage Closure Device Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 27‑2: Left Atrial Appendage Closure Device Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 27‑3: Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 |
| Figure 27‑4: Units Sold by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 |
| Figure 27‑5: Average Selling Price by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (€) |
| Figure 27‑6: Average Selling Price by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (US$) |
| Figure 27‑7: Market Value by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (€M) |
| Figure 27‑8: Market Value by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (US$M) |
| Figure 27‑9: Endocardial Market, Europe, 2020 – 2030 |
| Figure 27‑10: Units Sold by Country, Endocardial Market, Europe, 2020 – 2030 |
| Figure 27‑11: Average Selling Price by Country, Endocardial Market, Europe, 2020 – 2030 (€) |
| Figure 27‑12: Average Selling Price by Country, Endocardial Market, Europe, 2020 – 2030 (US$) |
| Figure 27‑13: Market Value by Country, Endocardial Market, Europe, 2020 – 2030 (€M) |
| Figure 27‑14: Market Value by Country, Endocardial Market, Europe, 2020 – 2030 (US$M) |
| Figure 27‑15: Epicardial Clip Market, Europe, 2020 – 2030 |
| Figure 27‑16: Units Sold by Country, Epicardial Clip Market, Europe, 2020 – 2030 |
| Figure 27‑17: Average Selling Price by Country, Epicardial Clip Market, Europe, 2020 – 2030 (€) |
| Figure 27‑18: Average Selling Price by Country, Epicardial Clip Market, Europe, 2020 – 2030 (US$) |
| Figure 27‑19: Market Value by Country, Epicardial Clip Market, Europe, 2020 – 2030 (€M) |
| Figure 27‑20: Market Value by Country, Epicardial Clip Market, Europe, 2020 – 2030 (US$M) |
| Figure 27‑21: Epicardial Suture Market, Europe, 2020 – 2030 |
| Figure 27‑22: Units Sold by Country, Epicardial Suture Market, Europe, 2020 – 2030 |
| Figure 27‑23: Average Selling Price by Country, Epicardial Suture Market, Europe, 2020 – 2030 (€) |
| Figure 27‑24: Average Selling Price by Country, Epicardial Suture Market, Europe, 2020 – 2030 (US$) |
| Figure 27‑25: Market Value by Country, Epicardial Suture Market, Europe, 2020 – 2030 (€M) |
| Figure 27‑26: Market Value by Country, Epicardial Suture Market, Europe, 2020 – 2030 (US$M) |
| Figure 27‑27: Leading Competitors, Left Atrial Appendage Closure Device Market, Europe, 2023 |
| Figure 28‑1: Preshaped Guidewire Market, Europe, 2020 – 2030 |
| Figure 28‑2: Units Sold by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 |
| Figure 28‑3: Average Selling Price by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (€) |
| Figure 28‑4: Average Selling Price by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (US$) |
| Figure 28‑5: Market Value by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (€M) |
| Figure 28‑6: Market Value by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (US$M) |
| Figure 28‑7: Leading Competitors, Preshaped Guidewire Market, Europe, 2023 |
| Figure 29‑1: ECMO Market by Segment, Europe, 2020 – 2030 (€M) |
| Figure 29‑2: ECMO Market by Segment, Europe, 2020 – 2030 (US$M) |
| Figure 29‑3: ECMO Disposables Market, Europe, 2020 – 2030 |
| Figure 29‑4: Units Sold by Country, ECMO Disposables Market, Europe, 2020 – 2030 |
| Figure 29‑5: Average Selling Price by Country, ECMO Disposables Market, Europe, 2020 – 2030 (€) |
| Figure 29‑6: Average Selling Price by Country, ECMO Disposables Market, Europe, 2020 – 2030 (US$) |
| Figure 29‑7: Market Value by Country, ECMO Disposables Market, Europe, 2020 – 2030 (€M) |
| Figure 29‑8: Market Value by Country, ECMO Disposables Market, Europe, 2020 – 2030 (US$M) |
| Figure 29‑9: ECMO Machine Market, Europe, 2020 – 2030 |
| Figure 29‑10: Units Sold by Country, ECMO Machine Market, Europe, 2020 – 2030 |
| Figure 29‑11: Average Selling Price by Country, ECMO Machine Market, Europe, 2020 – 2030 (€) |
| Figure 29‑12: Average Selling Price by Country, ECMO Machine Market, Europe, 2020 – 2030 (US$) |
| Figure 29‑13: Market Value by Country, ECMO Machine Market, Europe, 2020 – 2030 (€M) |
| Figure 29‑14: Market Value by Country, ECMO Machine Market, Europe, 2020 – 2030 (US$M) |
| Figure 29‑15: Leading Competitors, ECMO Market, Europe, 2023 |
In 2023, Edwards Lifesciences emerged as the primary player in the cardiac surgery market, largely attributed to its dominance in the Transcatheter Heart Valve Replacement (THVR) segment. The cornerstone of Edwards Lifesciences’ THVR offerings includes the SAPIEN 3 ULTRA®, SAPIEN 3®, and SAPIEN XT®. The company also exhibits a robust presence in the tissue heart valve and annuloplasty segments.
